1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRIME MEDICINE INC
Prime Medicine Inc
XNAS: PRME
3.12 -0.02 (-0.64%)
4.7M
XNAS Volume

XNAS 18 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Prime Medicine Inc - PRME - stock price prediction, stock price target, analyst ratings from 14 analysts

Prime Medicine Inc has a share price target of US$ 7, revenue growth forecast of 154.2%, and profit growth estimate of 9.6% for FY26, based on top 14 analyst calls.